TL;DR •A major 2022 survey revealed significant differences between what psychedelic users want researched and what academic institutions prioritize. •While institutions focus heavily on medicalizing psychedelics for clinical trials, the community prioritizes best practices for non-clinical use and broader societal impacts. •Users expressed a strong...
TL;DR •A new systematic review of 25 studies found that psilocybin-assisted therapy (PAP) significantly reduces anxiety symptoms across various mental health conditions. •The treatment produced a large reduction in anxiety for patients who received it, showing promise as a potential alternative to traditional medications. •While...
TL;DR •A 2026 randomized clinical trial found that psilocybin with psychotherapy was linked to more cocaine-abstinent days than an active placebo with psychotherapy. •The trial included 40 adults with cocaine use disorder and used a single oral psilocybin dose plus manualized psychotherapy. •Participants who received...
TL;DR •A 2026 meta-synthesis found five themes that may explain how psychedelic experiences can support change in eating disorder treatment. •The themes were Mind-Body-Spirit, Emotional Processing, Navigating Challenges and Risks, Enabling Safe and Supportive Experiences, and Therapeutic Improvements. •Eating disorder research is still early, and...